메뉴 건너뛰기




Volumn 356, Issue 9227, 2000, Pages 359-365

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 0034730027     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02526-5     Document Type: Article
Times cited : (861)

References (23)
  • 1
    • 0027771190 scopus 로고
    • The Nordic Diltiazem Study: An intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy
    • NORDIL Study Group. The Nordic Diltiazem Study: an intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy. Blood Press 1993; 2: 312-21.
    • (1993) Blood Press , vol.2 , pp. 312-321
  • 2
    • 0024424101 scopus 로고
    • The 1989 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting
    • World Health Organization/International Society of Hypertension Fifth Mild Hypertension Conference. The 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 689-93.
    • (1989) J Hypertens , vol.7 , pp. 689-693
  • 3
    • 0027461577 scopus 로고
    • Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
    • Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-21.
    • (1993) N Engl J Med , vol.328 , pp. 914-921
    • Materson, B.J.1    Reda, D.J.2    Cushman, W.C.3
  • 4
    • 0024221113 scopus 로고
    • Left ventricular hypertrophy: Epidemiological insights from the Framingham Heart Study
    • Levy D. Left ventricular hypertrophy: epidemiological insights from the Framingham Heart Study. Drugs 1988; 35 (suppl 5): 1-5.
    • (1988) Drugs , vol.35 , Issue.5 SUPPL. , pp. 1-5
    • Levy, D.1
  • 5
    • 0025280867 scopus 로고
    • Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
    • Levy D, Garrison RJ, Sagae DD Kännel W B, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-66.
    • (1990) N Engl J Med , vol.322 , pp. 1561-1566
    • Levy, D.1    Garrison, R.J.2    Sagae, D.D.3    Kännel, W.B.4    Castelli, W.P.5
  • 6
    • 0026517517 scopus 로고
    • Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies
    • Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
    • (1992) Am J Hypertens , vol.5 , pp. 95-110
    • Dahlöf, B.1    Pennert, K.2    Hansson, L.3
  • 7
    • 0029962323 scopus 로고    scopus 로고
    • Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
    • Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996; 275: 1507-13.
    • (1996) JAMA , vol.275 , pp. 1507-1513
    • Schmieder, R.E.1    Martus, P.2    Klingbeil, A.3
  • 8
    • 0000140996 scopus 로고    scopus 로고
    • Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment
    • Hansson L, Birkenhäger WH, eds. Amsterdam: Elsevier Science BV
    • Jennings GL, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: Hansson L, Birkenhäger WH, eds. Handbook of hypertension, Vol 18: assessment of hypertensive organ damage. Amsterdam: Elsevier Science BV, 1997: 184-223.
    • (1997) Handbook of Hypertension, Vol 18: Assessment of Hypertensive Organ Damage , vol.18 , pp. 184-223
    • Jennings, G.L.1    Wong, J.2
  • 9
    • 0031908811 scopus 로고    scopus 로고
    • Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
    • Schmieder RE, Schlaich MP, Klingbeil AU, Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant 1998; 13: 564-69.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 564-569
    • Schmieder, R.E.1    Schlaich, M.P.2    Klingbeil, A.U.3    Martus, P.4
  • 10
    • 0025347391 scopus 로고
    • Blood pressure, stroke, and coronary heart disease, part 2: Short-term reductions in blood pressure-over-view of randomised drug trials in their epidemiological context
    • Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, part 2: short-term reductions in blood pressure-over-view of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
    • (1990) Lancet , vol.335 , pp. 827-838
    • Collins, R.1    Peto, R.2    MacMahon, S.3
  • 11
    • 0029830418 scopus 로고    scopus 로고
    • Shanghai trial of nifedipine in the elderly (STONE)
    • Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-45.
    • (1996) J Hypertens , vol.14 , pp. 1237-1245
    • Gong, L.1    Zhang, W.2    Zhu, Y.3
  • 12
    • 0343487983 scopus 로고    scopus 로고
    • Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
    • Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
    • (1997) Lancet , vol.350 , pp. 757-764
    • Staessen, J.A.1    Fagard, R.2    Thijs, L.3
  • 13
    • 0031769003 scopus 로고    scopus 로고
    • Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension
    • Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-29.
    • (1998) J Hypertens , vol.16 , pp. 1823-1829
    • Liu, L.1    Wang, J.G.2    Gong, L.3    Liu, G.4    Staessen, J.A.5
  • 14
    • 0033589756 scopus 로고    scopus 로고
    • Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension2 study
    • Hansson L, Lindholm LH, Ekbom T, et al, for the STOPHypertension-2 study group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension2 study. Lancet 1999; 354: 1751-56.
    • (1999) Lancet , vol.354 , pp. 1751-1756
    • Hansson, L.1    Lindholm, L.H.2    Ekbom, T.3
  • 15
    • 0026911107 scopus 로고
    • Prospective Randomized Open Blinded Endpoint (PROBE) study: A novel design for intervention trials
    • Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded Endpoint (PROBE) study: a novel design for intervention trials. Blood Press 1992; 1: 113-19.
    • (1992) Blood Press , vol.1 , pp. 113-119
    • Hansson, L.1    Hedner, T.2    Dahlöf, B.3
  • 16
    • 0033494164 scopus 로고    scopus 로고
    • Progress report on the Nordic Diltiazem study (NORDIL): An outcome study in hypertensive patients
    • Hedner T, for the NORDIL Group. Progress report on the Nordic Diltiazem study (NORDIL): an outcome study in hypertensive patients. Blood Press 1999; 8: 296-99.
    • (1999) Blood Press , vol.8 , pp. 296-299
    • Hedner, T.1
  • 17
    • 0025287952 scopus 로고
    • Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension
    • Lund-Johansen P, Omvik P. Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension. Eur Heart J 1990; 11: 543-51.
    • (1990) Eur Heart J , vol.11 , pp. 543-551
    • Lund-Johansen, P.1    Omvik, P.2
  • 18
    • 0030807893 scopus 로고    scopus 로고
    • Effect of calcium antagonists on plama norepinephrine levels, heart rate and blood pressure
    • Grossman E, Messerli FH. Effect of calcium antagonists on plama norepinephrine levels, heart rate and blood pressure. Am J Cardiol 1997;80:1453-58.
    • (1997) Am J Cardiol , vol.80 , pp. 1453-1458
    • Grossman, E.1    Messerli, F.H.2
  • 19
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967-75.
    • (2000) JAMA , vol.283 , pp. 1967-1975
  • 20
    • 0034635831 scopus 로고    scopus 로고
    • Implications of discontinuation of doxazosin arm of ALLHAT
    • Messerli FH. Implications of discontinuation of doxazosin arm of ALLHAT. Lancet 2000; 355: 863-64.
    • (2000) Lancet , vol.355 , pp. 863-864
    • Messerli, F.H.1
  • 21
    • 0033986682 scopus 로고    scopus 로고
    • Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
    • Staessen JA, Birkenhäger WH, Fagard RH. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients. Eur Heart J 2000; 21: 2-7.
    • (2000) Eur Heart J , vol.21 , pp. 2-7
    • Staessen, J.A.1    Birkenhäger, W.H.2    Fagard, R.H.3
  • 22
    • 0033034404 scopus 로고    scopus 로고
    • Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
    • Hansson L, Lindholm LH, Niskanen L, et al, for the Captopril Prevention Project (CAPPP) Study Group.Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353: 611-16.
    • (1999) Lancet , vol.353 , pp. 611-616
    • Hansson, L.1    Lindholm, L.H.2    Niskanen, L.3
  • 23
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713-20.
    • (1998) BMJ , vol.317 , pp. 713-720


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.